Clinical Trial Update: Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating a cancer vaccine therapy in combination with sargramostim has completed in patients with stage III or IV cancer, including breast, lu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Lung Cancer
• Ovarian Cancer

Drugs mentioned

• Vaccine therapy
• sargramostim (sargramostim)

Snippet

Sponsor: University of Washington | Conditions: Breast Cancer, Lung Cancer | Phase 1 | Status: COMPLETED